Navigation Links
Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
Date:8/26/2009

larrychendesign.com/celadrin_30_second_tv.wmv" target="_new">http://www.larrychendesign.com/celadrin_30_second_tv.wmv

BioGuard(TM)

We have just received regional "in club" orders from the largest U.S. club warehouse for our most recent product, BioGuard(TM). BioGuard(TM) is a clinically proven pro-biotic uniquely designed for ear, nose, throat and immune system protection. This new innovative brand is designed to provide around the clock natural protection of the ear, nose and throat, the gateway to many illnesses. The strawberry flavored chewable tablet can be taken by all family members. If you live in the Pacific Northwest, you will be able to purchase BioGuard(TM) at the area's leading club warehouses starting in the beginning of October. Assuming a successful regional test, a nationwide launch could start as early as the first calendar quarter of 2010.

Fat Loss Product

Our intellectually protected, clinically proven, private label fat loss product has the potential to expand on a global basis. We sponsored clinical studies at the University of Minnesota and the University of Connecticut and have been recently published in the prestigious journal - The European Journal of Applied Physiology. This product offers us a unique opportunity to make a positive impact on the global problem associated with obesity.

New innovations in product and science are exciting but it is truly gratifying to see acceptance and the beginning stages of success of our products in the mass market, particularly the exciting opportunities in the top club warehouse. We have diligently focused our efforts and are now well positioned to prospectively post solid growth with our proprietary branded products.

Summarization

It goes without saying that this past year has brought about financial turmoil amongst n
'/>"/>

SOURCE Imagenetix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
3. Tone Deafness Explained, from the Harvard Health Letter
4. CEL-SCI Corporation Releases Letter to Shareholders
5. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
6. An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R)
7. Strykers Biotech Division Receives FDA Warning Letter
8. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
9. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
10. U.S. FDA Issues Action Letter for Sugammadex
11. September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , NEW YORK, Nov. 20 R...ch report is available in its catalogue. ,, Bl...nts - A World Market Analysis ,, http://www....g--Measurement-Instruments---A-World-Market-Analys...p;utm_campaign=prnewswire ,, Measurement of b...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 R...ch report is available in its catalogue. ,, Pi...ve ,, http://www.reportlinker.com/p0164373/P...tml#utm_source=prnewswire&utm_medium=pr&ut...rs are treated as an integral part of any research...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ,...research report is available in its catalogue. ,... ,, http://www.reportlinker.com/p0164741/Glob..._source=prnewswire&utm_medium=pr&utm_campa...st biopsy devices includes the spring loaded core ...
Breaking Medicine Technology:Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Kidney Paired Donation 3A 16 Patients Four Hospitals Four States 50917 1Kidney Paired Donation 3A 16 Patients Four Hospitals Four States 50917 2Kidney Paired Donation 3A 16 Patients Four Hospitals Four States 50917 3Celebrities to Gather to Support the Ninth Annual Starkey Hearing Foundation So the World May Hear Awards Gala 12917 1Celebrities to Gather to Support the Ninth Annual Starkey Hearing Foundation So the World May Hear Awards Gala 12917 2Celebrities to Gather to Support the Ninth Annual Starkey Hearing Foundation So the World May Hear Awards Gala 12917 3Operation for aneurysm yields nearly normal longevity 50911 1Operation for aneurysm yields nearly normal longevity 50911 2
... Fast Track Designation from FDA, Favorable Scient...n-Small Cell Lung Cancer Monotherap...Giuseppe Giaccone,Chief of the Medical Oncology Br...e final results from a positive double-blind,place...a in non-small cell,lung cancer (NSCLC). The data ...
...ns Study Represents Largest Patient Po...c, Inc.,(Nasdaq: HOLX ) a diversified medical tec... diagnostics, and interventional devices dedicated...nnounced the publication of a,study evaluating the...S),one-, two- and three-years after treatment. The...
Other Medicine Technology:Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 2Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 3Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 4Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 5Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 6Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 7Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 2Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 3Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 4
(Date:11/20/2009)...J, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharma...ting of Shareholders will be held on Monday, Decem...sider approval of two special resolutions. The fir...the sale of all or substantially all of the assets...or in the asset purchase agreement dated November ...
(Date:11/20/2009)....J., Nov. 20 Rates of in...peaked in late October, but the pandemic flu virus...all age groups, including the elderly, according t...NYSE: DGX ), the world,s leading provider of dia...In its most recent Quest Diagnostics Health Trends...
(Date:11/20/2009).... 20 The following is a... the Nevada Health Care Association: ,, "The Ne...hanks Senate Majority Leader Harry Reid for his le... our goal of protecting every Nevada seniors, ongo...rving the strength and viability of our state,s vi...
(Date:11/20/2009)...November 20, 2009Emergency medical service (EMS) p...350,000 cardiac arrests each year. Only 5 to 10 p...rvive. Better quality cardiopulmonary resuscitati... be associated with better patient outcome. The R...est clinical research network to study prehospital...
(Date:11/20/2009)...s high and is expected to continue, CDC says, , ...e areas of the United States are seeing declines i...al said Friday, and while the disease remains wide...s reported last week. , "We are beginning to se...ountry, but there is still a lot of influenza ever...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
... (NSF) is a newly identified debilitating and pain...ilure and is characterized by a thickening and har...d legs but it can also affect internal organs and ...ion has been linked to gadolinium, a contrast agen...
...problems in ones neighborhood are associated with ...s, according to researchers in Vancouver, Canada. ...an important factor in asthma manifestations in yo... Edith Chen, Ph.D., of the University of British ...
...atives, Inc.,(Nasdaq: MTXX ), an over-the-counter...ucts that provide consumers with "Better Ways to G...tober 3, 2007, at the,William Blair & Company Smal....com . Interested parties,should login 15 minutes ...
... musicians who play them, Irish researchers say ,...Banning smoking in bars is not only salve for the ... Irish workplaces has improved air quality in Iris...king at the health effects of the smoking ban on h...
...for Non Media types, its,hard not to notice that B...ely and from all indications, something is definit...ote however, a patient came in recently for a dent...t,on top of that pile was ... you guessed it, "Bri...
...cs, a leading innovator,and provider of intelligen...ed a partnership with SigmaSoft International, a g...ns for clinical trials. The two companies,collabor...ent and concomitant medication terminology to faci...
Other Medicine News:Health News:Higher death rates in kidney patients with newly recognized disease 2Health News:Higher death rates in kidney patients with newly recognized disease 3Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 2Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 3Health News:Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference 2Health News:Accordions Breathe Easier Since Smoking Ban 2Health News:SigmaSoft International Partners with Netrics to Create MedDRA and WHODrug Productivity Tool 2
SureStep Methadone (MTD)
COC/MAMPII/MOP/THC/AMPII/BAR/BZO300/MTD/TCA
SureStep THC/COC/MAMPII
SureStep Barbiturates (BAR)
Medicine Products: